Abeona Therapeutics ABEO 深 滬
等待開盤 09-08 09:30:00 美东时间
6.00
+0.070
+1.18%
華盛通- 最 高6.02
- 今 開5.89
- 成交量 86.65万股
- 最 低 5.85
- 昨 收 5.93
- 總市值 3.43亿
- 52周最高 7.65
- 市盈率 靜 5.92
- 換手率 1.52%
- 52周最低 4.00
- 委 比 -5.47%
- 總股本 5718.40万
- 歷史最高 750.00
- 量 比 0.95
- 振 幅 2.87%
- 歷史最低 2.19
- 每 手 1
- 風險率 0.69%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
Oppenheimer Maintains Outperform on Abeona Therapeutics, Lowers Price Target to $21
Oppenheimer analyst Jeff Jones maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and lowers the price target from $22 to $21.
08-15 01:00
Abeona Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
Abeona Therapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.
08-13 19:59
Abeona Therapeutics Activates Cincinnati Children’s As Seventh Qualified Treatment Center For Administration Of ZEVASKYN To Treat Wounds In Patients With Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the activation of Cincinnati Children’s as the seventh Qualified Treatment Center (QTC) for the administration of ZEVASKYN® (prademagene zami...
07-21 19:37
Abeona Therapeutics announces resignation of board member
Abeona Therapeutics ( ($ABEO) ) just unveiled an update. On June 11, 2026, Abeo...
06-12 20:01
Abeona Advances ABO-701 T-Cell Therapy Toward IND
Abeona Therapeutics ( ($ABEO) ) has shared an update. On June 3, 2026, Abeona T...
06-04 20:00
美股大行评级 | 瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
瑞穗上调戴尔目标价至350美元！华尔街齐上调迈威尔科技目标价；瑞银大幅上调Snowflake目标价
05-29 18:09
